Tag: Covaxin

The screening of children for trial of Covaxin, India's first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS here on Monday.

A latest study has found that both vaccines, Covishield and Covaxin elicited a good immune response after two doses, although seropositivity rates and the median anti-spike antibody titre was significantly higher in Covishield as compared to Covaxin.

Amid apprehensions over children being more prone to the virus in the third wave, indigenous pharma company Bharat Biotech has started its clinical trials of COVAXIN on children at Patna's All India Institute of Medical Sciences (AIIMS) hospital in Bihar.

Admitting that the State Capital does not have enough doses of COVAXIN for the age group of 18-44, the Commissioner of Bhubaneswar Municipal Corporation (BMC), Sanjay Singh on Thursday assured that it will be made available soon.

The Bhubaneswar Municipal Corporation (BMC) on Monday launched doorstep Covid-19 vaccination drive under its jurisdiction to inoculate people above 45 years of age at their homes.

Naba Das on Friday urged the Centre to allow the surplus vaccines, which the State has in stock for the age group of 45 and above, to be diverted for a short term.

For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chain, manufacturers, regulators, and state and Central government agencies, it added.

"The World Health Organisation (WHO) has not taken any decision on banning people from travelling who have been vaccinated with Covaxin. Covaxin is the one of the most effective vaccines to date."

Bharat Biotech plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production of vaccines based on inactivated Vero Cell Platform Technology, under stringent levels of GMP and biosafety. 

Peer-review publication, Clinical Infectious Diseases, has noted that Covaxin demonstrates protection against the new Covid-19 variants.

Bharat Biotech has been directly supplying its Covid-19 vaccine Covaxin to 18 states since May 1

Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states.

Bhubaneswar: In order to ramp up the vaccination drive in the State, Odisha government on Thursday said that people interested to inoculate themselves against Covid-19 at private hospitals can do…

Bhubaneswar: The third phase vaccination drive kicked off today in Bhubaneswar for the age group of 18 and 44. The Bhubaneswar Municipal Corporation (BMC) has initiated the exercise as decided…

Bhubaneswar: Voices of dissent have grown louder within the private medical community and political corridors in Odisha against the disparity in the prices of vaccine in Private and Government run…